Tumors had frequent and multiple deletions of miRs with predicted targets for IGF2BP1, an mRNA-binding protein with a suspected tumorigenic role in several malignancies, including pancreatic, colorectal, breast, and ovarian cancers [38]. This evidence concerns the gene IGF2BP1 and ovarian carcinoma.